FDA NDC Directory · JSON-LD · Markdown

Lithium Carbonate

NDC 0054-0021 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA076832
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsLITHIUM CARBONATE (300 mg/1)
Marketing started20041028
Package count2

External sources

Source: openFDA. Public-domain (CC0).